3Nelson DR, Lauwers GY, Lau JY, et al. Intemeukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trail of interferon nonresponders. Gastroenterology, 2000, 118: 655-660.
4Friedman SL. Cytokins and fibrogenesis. Semi Liver Dis, 1999, 19:129-140.
4De Bleser PJ,Niki T,Rogiers V,et al.Transforming growth factor-beta gene expression in normal and fibrotic rat liver.J Hepatol,1997,26:886-893.
5Friedman SL.Cytokines and fibrogenesis.Semin Liver Dis,1999,19:129-140.
6Louis H,Le Moine O,Peny MO,et al.Hepatoprotective role of interleukin-10 in galactosamine/lipopolysac charide mouse liver injury.Gastroenterology,1997,112:935-942.
7Reitamo S,Remitz A,Tamai K,et al.Interleukin-10 modulates type Ⅰ collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.J Clin Invest,1994,94:2489-2492.
8Nelson DR,Lauwers GY,Lau JY,et al.Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders.Gastroenterology,2000,118:655-660.
6Valkova M. Hepatic fibrogenesis[J]. Bratisl Lek Listy, 2002, 103(2): 76-85.
7Nagaki M, Tanaka M, Sugiyama A, et al. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or llipopolysaccharide in galactosamine-sensitized mice[J]. J Hepatol, 1999, 31(5): 815-824.
8Reitamo S, Remitz A, Tamai K, et al. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts[J]. J Clin Invest, 1994, 94(6): 2489-2492.